Embecta Corp., a global diabetes care company with a century-long history in insulin delivery, will host an Analyst and Investor Day on May 22, 2025, in New York City. The event, which will run from 9 ...
Shares are trading at a reported 4.1x forward earnings, offer a 5.2% dividend yield, and the stock is down more than 40% YTD, thus representing a fat discount to recent prices. Seems like a bargain at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results